Cerebriu featured in Health Europa: Machine learning for diagnostic medical imaging

Cerebriu’s CE approved product Apollo was featured heavily in this Health Europa article focusing on our aims to scale up clinical support through faster personalised diagnostic medical imaging.

“While Danish medical technology provider Cerebriu is only a year and a half old, its products are the result of a decade’s worth of research. CEO Robert Lauritzen speaks to HEQ about the ways in which Cerebriu Apollo technology can boost clinical workflow and provide support to practitioners through faster personalized diagnostic medical imaging.”

The article goes on to give an account of:

  1. What Cerebriu Apollo is?
  2. How it can benefit healthcare in practice?
  3. What issues concerning radiological workflows the technology aims to assists?
  4. The future progression of Cerebriu?

Read more here

Previous Post
Artificial intelligence to identify COVID-19 patients’ need for intensive care
Next Post
Eurostars Apollo Consortia Agreement Signed

Related Posts

Menu